<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03331237</url>
  </required_header>
  <id_info>
    <org_study_id>REC007</org_study_id>
    <nct_id>NCT03331237</nct_id>
  </id_info>
  <brief_title>Sparing Diaphragm; ISO Block Versus Low Volume Scalene Block</brief_title>
  <official_title>Shoulder Analgesia Sparing Diaphragm; ISO Block Versus Low Volume Scalene Block. A Randomized Controlled Double Blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Healthpoint Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Healthpoint Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      For shoulder analgesia, both ISO block and low volume scalene (LVS) block (using 5 ml of
      local anesthetics) are suggested to have a low incidence of hemi-diaphragmatic pariesis
      (HDP).

      The aim of this study was to compare the incidence of HDP and the analgesic efficacy of the
      LVS block versus ISO block.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 9, 2017</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>hemi-diaphragmatic pariesis</measure>
    <time_frame>2-4 hours</time_frame>
    <description>diaphragmatic caudal displacement will be measured (in cm) with real time ultrasound before the block performance and after the procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>analgesic efficacy (block success)</measure>
    <time_frame>2-4 hours</time_frame>
    <description>successful block = pain free (VAS 0) in recovery unit. VAS will be used to evaluate the pain (0 = pain free, 10= most sever pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>24 hours</time_frame>
    <description>if the patient is satisfied with the analgesia technique or not</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of analgesia</measure>
    <time_frame>24 hours</time_frame>
    <description>duration between the block performance and the first requesting of pain killer (morphine)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total morphine dose</measure>
    <time_frame>24 hours</time_frame>
    <description>the total morphine consumption within 24 hrs after the block performance</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Shoulder Arthropathy Associated With Other Conditions</condition>
  <arm_group>
    <arm_group_label>LVS group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>interscalene injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ISO group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>in this group all patients will receive ISO block.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>scalene block</intervention_name>
    <description>scalene block using 5ml of ropivacaine</description>
    <arm_group_label>LVS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ISO block</intervention_name>
    <description>ISO block is a combined block of suprascapular nerve and brachial plexus cords using a single puncture</description>
    <arm_group_label>ISO group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who were scheduled for arthroscopic shoulder surgery

        Exclusion Criteria:

          -  aged &lt;18y

          -  BMI &gt;35,

          -  ASA greater &gt;III,

          -  an infection at the injection site

          -  has a contraindication for laryngeal mask or the medications used in this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sabah Zahooruddin</last_name>
    <phone>009712 4929000</phone>
    <phone_ext>1304</phone_ext>
    <email>s.zahooruddin@helathpoint.ae</email>
  </overall_contact>
  <location>
    <facility>
      <name>Healthpoint Hospital</name>
      <address>
        <city>Abu Dhabi</city>
        <zip>112308</zip>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabah Zahooruddin</last_name>
      <phone>+971 2 4921304</phone>
      <email>s.zahooruddin@healthpoint.ae</email>
    </contact>
  </location>
  <location_countries>
    <country>United Arab Emirates</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2017</study_first_submitted>
  <study_first_submitted_qc>October 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2017</study_first_posted>
  <last_update_submitted>October 31, 2017</last_update_submitted>
  <last_update_submitted_qc>October 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Healthpoint Hospital</investigator_affiliation>
    <investigator_full_name>Ahmad Muhammad Taha</investigator_full_name>
    <investigator_title>Consultant of aneathesia</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

